CO38 Comparative Safety Assessment of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome after Percutaneous Coronary Intervention
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.136
https://www.valueinhealthjournal.com/article/S1098-3015(22)00337-0/fulltext
Section Title :
Section Order :
10114
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00337-0&doi=10.1016/j.jval.2022.04.136